Association between early PSA increase and clinical outcome in patients treated with enzalutamide for metastatic castration resistant prostate cancer.
Conteduca, V Crabb, S Scarpi, E Hanna, C Maines, F Joyce, Helen Fabbri, P Derosa, L Massari, F Lolli, C
Conteduca, V
Crabb, S
Scarpi, E
Hanna, C
Maines, F
Joyce, Helen
Fabbri, P
Derosa, L
Massari, F
Lolli, C
Citations
Altmetric:
Abstract
Description
Date
2016
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Association between early PSA increase and clinical outcome in patients treated with enzalutamide for metastatic castration resistant prostate cancer. 2016, 34(2):231-1 J Clin Oncol